Myanmar vs Suriname: Protecting minority investors (DB06-14 methodology) - Score
Myanmar
23.33
in 2013
Suriname
20
in 2013
Myanmar rank
182nd
Suriname rank
186th
Protecting minority investors (DB06-14 methodology) - Score over time
- Myanmar
- Suriname
How they compare
Myanmar currently reports 23.33 against 20 in Suriname, a difference of 3.33.
That makes Myanmar's figure about 1.2 times Suriname's.
Across all 9 years both countries report, Myanmar has been ahead every year.
Myanmar ranks 182nd and Suriname ranks 186th of 190 countries.
Myanmar has averaged higher in every one of the 2 decades both report.
Head to head by decade
| Decade | Myanmar | Suriname | Difference | Ahead |
|---|---|---|---|---|
| 2000s | 23.33 | 20 | 3.33 | Myanmar |
| 2010s | 23.33 | 20 | 3.33 | Myanmar |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher protecting minority investors (db06-14 methodology) - score, Myanmar or Suriname?
- Myanmar, at 23.33 against 20 in Suriname as of 2013.
- What is the difference in protecting minority investors (db06-14 methodology) - score between Myanmar and Suriname?
- 3.33, with Myanmar ahead.
- How many years of comparable data are there for Myanmar and Suriname?
- 9 years are reported by both, from 2005 to 2013.
- How do Myanmar and Suriname rank globally for protecting minority investors (db06-14 methodology) - score?
- Myanmar ranks 182nd and Suriname ranks 186th of 190 countries.
- Where does this data come from?
- The World Bank, published as Protecting minority investors (DB06-14 methodology) - Score. Statizoid refreshes it automatically from the source and publishes the full history for both places.
Individual pages
About this data
The score for protecting minority investors benchmarks economies with respect to the regulatory best practice on the indicator set. The score is indicated on a scale from 0 to 100, where 0 represents the worst regulatory performance and 100 the best regulatory performance, and is computed based on the methodology in the DB06-14 studies.